Psoriasis vulgaris is chronic skin disease that is linked to genetics and immune system. The most important predisposing genetic factor is human leukocyte antigen (HLA). This study was performed to determine the relationship between HLA-Cw6 allele and psoriasis vulgaris and the changes of nucleotide base squences, using observation method with a cross sectional comparative study. Samples were selected using consecutive sampling of 30 patients with psoriasis vulgaris attending the Dermatology and STD polyclinic at DR. M. Djamil Hospital. 30 healthy volunteers were selected as controls. The subjects' medical history was recorded followed by a dermatological examination, collection of samples, DNA isolation, then primers were designed for HLA-Cw6 allele, genes were sequencing and finally analyzed using PCR-SSP. The results were 20% of patients with psoriasis vulgaris carried HLA-Cw6 allele, while it was absent in the control group. This difference is statistically significant at the 5% level (p = 0.024). We found the changes of nucleotide base formations of HLA-Cw6. In conclusion, based on these observations, presence of the HLA-Cw6 allele is an important genetic risk factor for developing psoriasis vulgaris.
Introduction
Psoriasis vulgaris is a chronic skin disease that interferes with daily life resulting in high levels of morbidity. 1 It affects a patient's appearance 2 , reducing their quality of life 1, 2 , and impacting both the social and health systems. 1 Globally the incidence is 2-3 % of the population. 3, 4 Amongst patients at the Dermatology and STD polyclinic at the DR. M. Djamil Hospital in Padang, the prevalence of patients diagnosed with psoriasis is increasing; 2.8% in 2014 and 3.6% in 2016. Psoriasis is an autoimmune disease that is mediated by T cells, characterized by hyperproliferation of keratinocytes and is related to HLA (human leukocyte antigen) particularly the HLA-Cw6 allele. 5 Psoriasis is the result of an interaction between this hyperproliferation of keratinocytes and the infiltration and activation of immune cells. 4 The human leucocyte antigen (HLA) system is a gene locus that encodes a cell wall protein responsible for the regulation of the human immune system. Human leucocyte antigen-Cw6 is a class one variant of MHC (major histocompatibiy complex) related to the early onset of psoriasis vulgaris and primarily responds with a T cell expression of CD-8+. Type I psoriasis occurs in patients before 40 years of age, often reoccurs, runs in families, has a more severe clinical presentation and is primarily related to HLA-Cw6. Type II psoriasis has a later onset, does not occur in family histories and clinical symptoms are less severe. It is related to HLA-Cw2 and -B27, with only a weak correlation with HLA-Cw6. 6 HLA-Cw6 incidence varies with racial background and geography and also this chronic recidive disease is hard to treat. Hence, this study focused on the role of HLA-Cw6 in psoriasis vulgaris patients and the changes of nucleotide base squences.
Materials and Methods
Consecutive random sampling was used to select from the subjects fulfilling the criteria. A physical examination was conducted to determine the severity of the psoriasis (PASI score). A 5cc blood sample was taken from the cubital vein of each subject. This was used to check for the presence of HLA-Cw6 using a sequencespecific primer. DNA isolation was conducted using a Vivantis GF-1 Blood/ Cultured Cell DNA Geneaid Cat.No GB100 kit. Synthesis of the primer was done by Integrated DNA Technologies (IDT) Singapore. The reagent for PCR was KAPATaq Extra Hot Start (Cat. No. KK3606). Table 1 shows the characteristics of subjects in the two samples. Subject age was 51.0±15.1 with a mode of 46 to 56 years (23.3%). All subjects were 12 years old or above. Males slightly outnumbered females (53.3% compared to 46.7%) amongst psoriasis sufferers. 43.0% of psoriasis patients and 43.3% of control subjects had junior high school education and half of each group had a tertiary education. Table 2 shows 76.7% of patients had mild psoriasis, 16.7% moderate psoriasis and 6.6% had severe psoriasis, 76.7% first suffered the disease at or before the age of 40 while only 23.3% first experienced it after this age. 50% had suffered from the disease from between 5 and 15 years, 46.7% for five years or less and only 3.3% had suffered from psoriasis for more than 15 years. Bioinformatic study of the HLA-Cw6 was conducted using primer designed by Bunce & Welsh (1994) . The appropriateness of the primer was verified by alignment with the Homo Sapiens HLA-C gene sequence (NCBI Accession NG_029422.2) using the Geneious (version 7.0.6) software. Tables 3  and 4 show the primer for HLA-Cw6. PCR products are 336 bp respectively (adapted from Bunce & Welsh, 1994) (Figures 1-3 ).
Results

Discussion
The literature suggests that the onset of psoriasis vulgaris can occur at any age from infancy until the seventies. There are two peaks for onset age, between 20-30 and 50-60. 7, 8 Henseler and Christopher (1985) 9 divided psoriasis into two types. Type 1 usually has an onset before the age of 40 and is coincident with the HLA-Cw6 allele in 85% of the cases so runs in families. Type II has a later onset and is unrelated to HLA. 
also found that psoriasis type I (60.2%) was more common that type II (36.9%). 10 Similarly, over three quarters (76.7%) of the patients in our study first contracted psoriasis vulgaris before they were 40 years old.
Psoriasis vulgaris afflicts males and females equally. Most psoriasis patients in this study were aged between 46 and 56 and the number of males and females was almost the same (53.3% and 46.7%). A disproportionate number of patients had higher levels of education and the majority had mild cases of the disease. This maybe because more educated and social aware sufferers feel embarrassed about this disease so seek early treatment. More than half the patients in our study had suffered from the disease for more than 5 years. This is in line with the chronic recidive nature of psoriasis vulgaris reported in the literature.
The presence of HLA-Cw6 in 20% of the psoriasis vulgaris patients and not in the control group compares with the findings of Amr et al., (2010) allele for suseptability to psoriasis vulgaris in West India. 5 Human leucocyte antigenCw6 has the ability to produce peptides and trigger a CD8+ T cell response. 12 HLA-Cw6 is a highly significant marker for the predicting risk of developing psoriasis vulgaris. 13 A study amongst the Chinese population reported that a HLA-Cw6 positive individual has an 8.33 x greater risk of developing psoriasis compared to individuals who are HLA-Cw6 negative. 14 
Conclusions
In this research HLA-Cw6 was only found in psoriasis vulgaris patients, not in the control group. We also found some changes of nucleotide base sequences. More research is needed to investigate the other genetic and immunological factors that play a role in clinical psoriasis vulgaris. 
